Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Adamis Pharmaceuticals (ADMP) PT Raised to Street High $13 at Maxim Group
-
ContraVir Pharmaceuticals Announces $10.8 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Maxim Group Downgrades Keryx Biopharmaceuticals (KERX) to Hold Following Merger
-
Entera Bio Ltd. (ENTX) IPO Opens 9% Lower
-
UPDATE: Entera Bio Ltd. (ENTX) Prices 1.4M Unit IPO at $8/Unit
-
Entera Bio Ltd. Announces Pricing of Initial Public Offering
-
UPDATE: Maxim Group Starts PAVmed (PAVM) at Buy
-
Maxim Group Starts Titan Medical (TMDI) at Buy
-
Maxim Group Assumes MYnd Analytics (MYND), Upgrades to Buy
-
Chipotle Mexican Grill (CMG) PT Lowered to $420 at Maxim Group
-
Chipotle CEO plans marketing blitz, closing up to 65 stores
-
Pre-Open Movers 06/27: (DFBG) (CARA) (I) Higher; (AQXP) (PTIE) (DRRX) Lower (more...)
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
UPDATE: Maxim Group Starts IntelGenx Technologies Corp (IGXT) at Buy
-
Maxim Group Starts VistaGen Therapeutics (VTGN) at Buy
-
Maxim Group Starts SCYNEXIS (SCYX) at Buy
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
National Beverage (FIZZ): LaCroix Growth is Decelerating; Additional Corporate Governance Concerns Surface - Maxim Group
-
Cytori Therapeutics Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
BeyondSpring Inc. (BYSI) PT Lowered to $48 at Maxim Group
-
Galmed Pharma (GLMD) Prices 5M Share Common Offering at $15/Sh
-
Galmed Pharmaceuticals Ltd. Announces Pricing of Public Offering of Ordinary Shares
-
Maxim Group Maintains Bullish View on BioLineRx (BLRX) Amid Follow-Up Data for BL-8040
-
Galmed Pharma (GLMD) Proposed $75M Public Offering of Ordinary Shares
-
Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares
-
Maxim Group Upgrades TrovaGene (TROV) to Buy
-
bluebird bio (BLUE) Valuation Upside is Incremental Says Maxim, Remains Sidelined
-
Maxim Group Starts EuroDry Ltd. (EDRY) at Buy
-
UPDATE: Cheesecake Factory (CAKE) PT Raised to Street High $60 at Maxim Group; Sees Decision on Potential Acquisition to Coming Soon
-
Dawson James Securities Announces the Closing of Oversubscribed $10,350,000 Rights Offering for PAVmed, Inc.
-
Dawson James Securities Announces the Closing of Oversubscribed $10,350,000 Rights Offering for PAVmed, Inc.
-
PAVmed Closes Oversubscribed Rights Offering for Gross Proceeds of $10,350,000
-
Galmed Pharmaceuticals (GLMD) PT Raised to $30 at Maxim Group
-
ContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
Cytori Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
-
Nxt-ID, Inc. (NXTD) PT Lowered to $4 at Maxim Group
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
PAVmed to Receive $10.4 Million in Gross Proceeds from Oversubscribed Rights Offering
-
Maxim Group Downgrades Sientra (SIEN) to Hold
-
Mesoblast (MESO) Upcoming Data Readouts Should Boost Valuation - Maxim
-
Viking Therapeutics (VKTX) Prices 7.5M Common Stock Offering at $9/Share
-
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
-
BrainStorm Announces Exercise of Warrants Resulting in Cash Proceeds of ~$12.3 Million at $5 Share
-
ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
-
Palo Alto Networks (PANW) PT Raised to $262 at Maxim Group
-
VMware (VMW) PT Raised to $142 at Maxim Group
-
Maxim Group Starts Pitney Bowes (PBI) at Buy
-
Maxim Group Starts Stamps.com (STMP) at Buy; 'First Class Growth Story'

